Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Bernard L. Zidar"'
Autor:
Leslie R. Laufman, Bernard L. Zidar, A R N Kathy Stydnicki, William J. Hicks, Jerry T. Guy, Chuck C. Cho, C. Harris Spiridonidis, Mark L Segal, Donn C. Young, Judith W. Noltimier
Publikováno v:
Cancer. 75:1586-1593
Background. The assessment of treatment efficacy in nonsmall cell lung cancer (NSCLC) is limited by the lack of a clear association between clinical response and survival. The prognostic usefulness of treatment-induced tumor-marker declines in NSCLC
Autor:
Michael D. Keppen, H. Irving Pierce, Barbara Metch, Liboria Militello, Jeffrey L. Berenberg, Bernard L. Zidar, Stanley P. Balcerzak
Publikováno v:
Cancer. 70:2547-2551
Background. Malignant mesothelioma is a highly treatment-resistant neoplasm. This study represents an attempt to define an effective form of systemic therapy. Methods. Twenty-six patients with unresectable diffuse malignant mesothelioma were enrolled
Autor:
Roberta N. Mazur, Sheryl R. Simon, Robert N. Raju, Reginald P. Pugh, Stanley E. Shackney, Bernard L. Zidar, John W. Mucenski
Publikováno v:
Cancer. 66:411-417
A drug schedule has been devised based on a strategy of G2 blockade followed by prolonged infusion of tubulin-binding agents. The regimen consists of doxorubicin 32 mg/m2 i.v. and cyclophosphamide 320 mg/m2 i.v. on day 1 followed by vinblastine (0.3
Autor:
Bernard L. Zidar
Publikováno v:
New England Journal of Medicine. 332:1204-1204
Figure 1. A 27-year-old man who was seropositive for the human immunodeficiency virus presented with severe periorbital and facial edema (Panel A) and generalized cutaneous Kaposi's sarcoma. Note the lesion (arrows) on the nose. Computed tomography (
Autor:
R N Raju, Bernard L. Zidar, R J Hartsock, R H Glew, Robert E. Lee, S E Shackney, K L LaMarco, R P Pugh
Publikováno v:
American Journal of Clinical Pathology. 87:533-536
The authors studied an 18-year-old woman with stage IIIB nodular sclerosis Hodgkin's disease whose bone marrow contained abnormal storage cells that resembled Gaucher cells by light microscopic examination ("pseudo-Gaucher" cells). Electron microscop
Autor:
George J. Magovern, Robert N. Raju, Madhuri Singh, Sheryl R. Simon, Scott Wang, Stanley E. Shackney, Bernard L. Zidar, Reginald P. Pugh, Kenneth S. Weiss, Anthony R. Lupetin
Publikováno v:
Cancer. 60:1238-1242
A patient with a pleomorphic intravascular leiomyosarcoma of the great vessels of the neck and mediastinum presented clinically with a superior vena cava syndrome. A latent period of 29 years elapsed between receiving orthovoltage radiation to the ne
Autor:
Robert J. Hartsock, Frank Hryschko, Thomas A. Lyons, Mustafa H. Adatepe, Bernard L. Zidar, Laibe Kessler
Publikováno v:
Clinical Nuclear Medicine. 7:497-501
This paper summarizes the clinical and diagnostic features of five reports of patients with intracerebral, non-Hodgkin's lymphoma. In three patients the brain lesion was the only evidence of lymphoma, while two patients also had concomitant systemic
Publikováno v:
American Journal of Hematology. 3:177-185
Following extensive bowel resection, a young woman experienced severe malnutrition; subsequent administration of parenteral nutrition precipitated the copper deficiency syndrome. This consisted of hypocupremia, subnormal ceruloplasmin levels, anemia,
Autor:
Laurence H. Baker, R. Lee Bloom, Bernard L. Zidar, Lewis M. Schiffer, Donna G. Horne, Kalpana A. Vaidya, Robert N. Raju, Reginald P. Pugh
Publikováno v:
Cancer. 52:1788-1791
Six patients with unresectable malignant mesothelioma were treated with chemotherapy consisting of doxorubicin and cisplatin every 3 weeks. One patient with paratesticular mesothelioma metastatic to lungs entered complete remission for 8 months; his
Autor:
Bernard L. Zidar, H. I. Pierce, Stephanie Green, Stanley P. Balcerzak, Liboria Militello, Ralph W. Roach
Publikováno v:
Investigational New Drugs. 6:223-226
Cisplatin was given intravenously to 35 evaluable patients with unresectable malignant mesothelioma on Southwest Oncology Group (SWOG) Study 8418. Five patients (14.3%) achieved partial response with median response duration of six months (range 2-12